HOFFMANN EITLE English

Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.

このページには日本語版がございません。

Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

Andreas Stefferl

Contact vCard

P +49 (0) 89 92 40 90

HOFFMANN EITLE
Arabellastraße 30
81925 Munich

For security reasons we give you the possibility to communicate with Andreas Stefferl in an encrypted form by e-mail.

Biotechnology

Andreas Stefferl

Partner

Dr., Mag. rer. nat. (Biol.)., German and European Patent Attorney

Profile

Languages: English, German

Specialisation

Opinion work; examination, opposition and appeal proceedings before the European and German Patent Offices and before the Federal Patent Court, mainly in the field of biotechnological inventions.

Professional memberships

Patent Attorney Bar Association, EPI.

Career

Studied biology at the University of Vienna and Victoria University of Manchester, UK. Diploma thesis in the field of neurobiology in 1995. Doctoral thesis at the Max-Planck-Institutes for Psychiatry and Neurobiology in the fields of neuroimmunology and neuroendocrinology of inflammatory diseases of the central nervous system, in particular multiple sclerosis. Doctoral thesis in 2000. Postdoctoral associate at the University of Vienna in 2000. Research analyst in a rating agency from 2001 to 2002. Investment manager at a venture capital firm specialised in biotechnology startup companies until 2003. With HOFFMANN EITLE since 2003. European Patent Attorney since 2007. German Patent Attorney since 2008.

recommendations

iam 1000

Stefferl “handles EPO proceedings with similar poise“ and “brings significant business nous to the table, thanks to stints as an investment manager at a venture capital firm and a research analyst at a rating agency and recommends him individually for prosecution and nullity.”